Report Description

The UAE intragastric balloons market is anticipated to observe an impressive growth during the forecast period, 2023-2027. The major factors include increasing prevalence of obesity, technological advancements, and customer preference for non-surgical and non-invasive procedures. An intragastric balloon is a saline- filled or gas-filled balloon that is placed inside the stomach for losing weight. It is inserted orally to restrict the amount of food stored by the stomach, thereby providing an early feeling of satiety. It also aids in eliminating the other health related concerns such as strokes, diabetes, and high blood pressure. Various advancements are done for optimal results and the reduction of associated difficulties. The other factor which are bolstering the market growth are changing lifestyle, increasing investments on healthcare sector, growing awareness and low price of intragastric balloon procedure.

Increasing Prevalence of Obesity

The increasing prevalence of obesity is one of the main reasons to drive the growth of the market. Owing to lack of inactiveness, deskbound jobs, alcohol consumptions and unhealthy eating habits, a significant portion of the world's population is suffering from weight-related health concerns. Thus, many physicians’ advice patients to lose weight due to which overweight and obese people opt for intragastric balloons method, as it serves as an effective non-surgical procedure. As per the Central Intelligence Agency World Factbook, the UAE has an obesity prevalence rate of 31.7%.

Preference Towards Non-Surgical and Non-Invasive Procedures

Nowadays, due to increase in awareness among masses regarding the weight-loss procedures, obese and overweight adults prefer non-surgical and non-invasive treatments, including intragastric balloons. Intragastric balloons serves as an effective non-surgical substitute for weight-loss as they are inserted orally and do not require any incisions on the body. Also, it has fast recovery rate with less discomfort. Likewise, growing preference for non- invasive surgeries are bolstering the market growth.

Technological Advancements

Technological advancements and product innovations are the key factor influencing the market. Manufacturers are focusing on creating product variants with minimal side-effects, such as gastric erosion, ulceration, and nausea. The advancements are done in intragastric balloons, by coupling dual and triple balloons to prevent the migration of device from stomach to intestine, thus, in turn reduce the risk intestinal obstruction. They are also designing balloons with adjustable gas/saline volumes. In UAE, allurion Technologies announced the availability of its Gastric Balloon technology, for people with age between 16 to 65 years in selected clinics, it is the first and only weight loss tool in the world without surgery, endoscopy, or anesthesia.

Download Free Sample Report

Market Segmentation

The UAE Intragastric balloons market is segmented into administration, balloon type, filling type, application, end user, and company. Based on administration, the market is divided into pill form and endoscopy. Based on balloon type, the market is divided into single, dual, and triple. Based on filling type, the market is divided into saline filled and gas filled. Based on application, the market is divided into obesity, diabetes, diet control, and others. Based on end user, the market is divided into hospitals & clinics, ambulatory surgical centers, and others. In terms of region, the market is segmented into Abu Dhabi, Dubai, Sharjah, and Rest of UAE.

 Market Players

Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC are some of the leading companies operating in the market.



Base Year


Historic Data

2017 – 2020

Estimated Year


Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, Volume Units and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, Volume forecast company share, competitive landscape, growth factors, and trends

Segments covered

·         Product

·         Application

·         End User

·         Company

Regional scope

 Abu Dhabi; Dubai; Sharjah; and Rest of UAE

Key companies profiled

Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Report Scope:

In this report, UAE intragastric balloons market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

·         UAE Intragastric balloons Market, By Administration:

    • Pill Form
    • Endoscopy

·         UAE Intragastric Balloons Market, By Balloon Type:

o    Single

o    Dual

o    Triple

·         UAE Intragastric balloons Market, By Filling Type:

    • Saline Filled
    • Gas Filled

·         UAE Intragastric balloons Market, By Application:

    • Obesity
    • Diabetes
    • Diet Control
    • Others

·         UAE Intragastric balloons Market, By End User:

    • Hospitals & Clinics
    • Ambulatory Care Centers
    • Others

·         UAE Intragastric balloons Market, By Region:

o    Abu Dhabi

o    Dubai

o    Sharjah

o    Rest of UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Intragastric balloons market

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Intragastric Balloons Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on UAE Intragastric Balloons Market

4.    Voice of Customer

5.    Executive Summary

6.    UAE Intragastric Balloons Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Administration (Pill Form v/s Endoscopy)

6.2.2.     By Balloon Type (Single, Dual, Triple)

6.2.3.     By Filling Type (Saline Filled v/s Gas Filled)

6.2.4.     By Application (Obesity, Diabetes, Diet Control, Others)

6.2.5.     By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)

6.2.6.     By Company (2021)

6.2.7.     By Region

6.3.  Product Market Map

7.    UAE Saline Filled Intragastric Balloons Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Application

7.2.2.     By End User

8.    UAE Gas Filled Intragastric Balloons Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Application

8.2.2.     By End User

9.    Market Dynamics

9.1.  Drivers

9.2.  Challenges

10.  Market Trends & Developments

11.  Policy & Regulatory Landscape

12.  UAE Economic Profile

13.  Competitive Landscape

13.1.              Obalon Therapeutics, Inc. (UAE)

13.2.              Allurion Technologies, Inc. (UAE)

13.3.              ReShape Lifesciences Inc (UAE)

13.4.              Silimed Inc. (UAE)

13.5.              Allergan Middle East Limited

13.6.              Vasmed UAE

13.7.              Life Mate Medical Equipment Trading LLC

14.  Strategic Recommendations

Figures and Tables

Frequently asked questions


Increasing prevalence of obesity, technological advancements, and customer preference for non-surgical and non-invasive procedures are driving the demand for the UAE intragastric balloons market.


Obalon Therapeutics, Inc. (UAE), Allurion Technologies, Inc. (UAE), ReShape Lifesciences Inc (UAE), Silimed Inc. (UAE), Allergan Middle East Limited, Vasmed UAE, and Life Mate Medical Equipment Trading LLC are the key players operating in the UAE intragastric balloons market.


Risks of acute pancreatitis, damage to the esophagus and overinflation associated with intragastric balloon are likely to hamper the growth of UAE intragastric balloons market.


Intragastric balloons is used in reducing weight by limiting how much an individual can eat..